FDA DEVICE FACTS
Cardinal Health ChemoPlus Full Coverage Gown, Closed Back, Cardinal Health ChemoPlus Full Coverage Gown, Open Back, Cardinal Health ChemoPlus Full Coverage Sleeve
Cardinal Health200, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Cardinal Health™ ChemoPl us™ Full Coverage Gown , Closed Back The Cardinal Health™ Ch emoPlus™ Full Coverage Gowns , Closed Back, are intended to protect healthcare personnel from exposure to chemothera py drugs during preparation, handling, and administration. The closed back gowns are single use, disposable medical devices provided sterile and non-sterile. The non-sterile, closed back gowns are not intended for use in the operating room. ChemoPlusTM Gowns Catalog Number Summary Catalog Number Product Description Size Sterility CT5502T Cardinal Health™ ChemoPlus™ Full Coverag e Gown Closed Back M Non-sterile CT5503T Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back L Non-sterile CT5504T Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back XL Non-sterile CT5505T Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back XXL Non-sterile CT5502TS Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back M Sterile CT5503TS Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back L Sterile CT5504TS Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back XL Sterile CT5505TS Cardinal Health™ ChemoPlus™ Full Coverage Gown Closed Back XXL Sterile The proposed gowns meet the barrier protection requirements of AAMI Level 3 per ANSI/AAMI Standard PB70:2012 Liquid Barrier Performance and Class ification of Protective Apparel and Drapes intended for use in Health Care Facilities. The gowns have been evaluated for resistance to permeation of various chemotherapy drugs per ASTM F739- 12, Standard Test Method for Permeatio n of Liquids and Gases Through Protective Clothing Materials Under Conditions of Continuous Contact. Chemotherapy drug permeation resistance, average standardized breakthrough time in minutes *: Carmustine [3.3 mg/ ml] >480 Cisplatin [1.0 mg/ml] >480 Cyclophosphamide [20 mg/ ml] >480 Cytarabine Hydrochloride [100 mg/ ml] >480 Dacarbazine [10 mg/ml] >480 Daunorubicin Hydrochloride [5 mg/ ml] >480 Doxorubicin Hydrochloride [2 mg /ml] > 480 Etopside [20 mg/ml] > 480 Fluorouracil [50 mg/ml] >480 lfosfamide [50 mg/ml] > 480 Methotrexate [25 mg /ml] >480 Mitomycin C [0.5 mg /ml] >480 Mitoxantrone [2.0 mg/ ml] >480 Paclitaxel [6 mg/ml] >480 Vincristine Sulfate [1 mg /ml] >480 *No permeation was detected at either the minimum detectable p ermeation or 0.1 μg/cm2/min When chemotherapy drugs are present, gown selection should be based on the specific type(s) of chemicals used. Users are recommended to review drug labeling or material safety data sheets for the ch emicals being used to determine an adequate level of protection. Cardinal Health™ ChemoPlus™ Full Coverage Gown , Open Back The Cardinal Health™ Ch emoPlus™ Full Coverage Gowns , Open Back, are intended to protect healthcare personnel from exposure to chemotherapy drugs during preparation, handling, and administration. The open back gowns are single use, disposable medical devices provided non-sterile. The open-back gown is non-protective in the back. The open -back gowns are not intended for use in the ope rating room. ChemoPlusTM Gowns Catalog Number Summary Catalog Number Product Description Size Sterility DP5003GT Cardinal Health™ ChemoPlus™ Full Coverage Gown Open Back M Non-Sterile DP5001GT Cardinal Health™ ChemoPlus™ Full Coverage Gown Open Back L Non-Sterile DP5002GT Cardinal Health™ ChemoPlus™ Full Coverage Gown Open Back XL Non-Sterile DP5004GT Cardinal Health™ ChemoPlus™ Full Coverage Gown Open Back XXL Non-Sterile The proposed gowns meet the barrier protection requirements of AAMI Level 3 per ANSI/AAMI Standard PB70:2012 Liquid Barrier Performance and Class ification of Protective Apparel and Drapes intended for use in Health Care Facilities. The gowns have been evaluated for resistance to permeation of various chemotherapy drugs per AST M F739-12, Standard Test Method for Permeation of Liquids and Gases Through Protective Clothing Materials Under Conditions of Continuous Contact. Chemotherapy drug permeation resistance, average standardized breakthrough time in minutes *: Carmustine [3.3 mg/ml] >480 Cisplatin [1.0 mg/ml] >480 Cyclophosphamide [20 mg/ ml] >480 Cytarabine Hydrochloride [100 mg/ ml] >480 Dacarbazine [10 mg/ml] >480 Daunorubicin Hydrochloride [5 mg/ ml] >480 Doxorubicin Hydrochloride [2 mg /ml] > 480 Etopside [20 mg/ml] > 480 Fluorouracil [50 mg/ml] >480 lfosfamide [50 mg/ml] > 480 Methotrexate [25 mg /ml] >480 Mitomycin C [0.5 mg /ml] >480 Mitoxantrone [2.0 mg/ ml] >480 Paclitaxel [6 mg/ml] >480 Vincristine Sulfate [1 mg /ml] >480 *No permeation was detected at either the minimum detectable p ermeation or 0.1 μg/cm2/min When chemotherapy drugs are present, gown selection should be based on the specific type(s) of chemicals used. Users are recommended to review drug labeling or material safety data sheets for the chemicals being used to determine an adequate lev el of protection.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。